PT-141 10 mg
29,90 €
PT-141 10 mg is a synthetic cyclic melanocortin research peptide supplied as a lyophilized powder. Also known as bremelanotide in pharmaceutical research, it is studied in connection with melanocortin receptors, central neurohormonal signaling, behavioral-response models and receptor-selectivity research.
Key product information:
- Compound: PT-141 / Bremelanotide
- Amount: 10 mg
- Form: Lyophilized powder
- Class: Cyclic melanocortin receptor agonist analog
- Intended use: Research use only
- Description
- Additional information
Description
A Peptide That Took MT2 Research in a New Direction
PT-141 comes from the same wider research family as Melanotan II, but its story soon moved in a different direction. While MT2 became known mainly for pigmentation-related research, PT-141 attracted attention for its connection with signals inside the brain and hormonal system. Researchers became interested in how melanocortin pathways may influence certain behavioral and neurohormonal responses.
PT-141 is therefore not simply another version of MT2. It is a separate research peptide with its own focus and research profile.
From MT2 Research to a Different Focus
PT-141 was developed from the same peptide-research line that produced Melanotan II. Small changes created a related but distinct molecule.
This explains why the two peptides are often mentioned together, but they should not be treated as the same compound.
MT2 is connected with several melanocortin receptors and is widely known for pigmentation research. PT-141 became more closely associated with research involving the brain, hormones and behavior.
Why the Brain Connection Matters
Some research compounds are studied for acting directly on blood vessels or other tissues. PT-141 follows a different path.
Its research focuses mainly on melanocortin signals inside the central nervous system. In simple terms, scientists are looking at how signals in the brain may influence hormonal and behavioral responses elsewhere in the body.
This makes PT-141 interesting because the observed response may begin in the brain rather than directly in the tissue where the final change is noticed.
More Than One Melanocortin Signal
The melanocortin system contains several types of receptors found in different parts of the body.
PT-141 may not communicate with every receptor in exactly the same way. The response can depend on which receptors are involved, where they are located and under what conditions the peptide is studied.
For this reason, PT-141 should be described as a peptide for melanocortin and neurohormonal research – not as a product that guarantees one specific behavioral or physical result.
Future Research Potential
Future research may help explain how melanocortin signals in the brain are connected with hormonal balance, motivation and selected behavioral responses.
Scientists may also learn why PT-141 behaves differently from Melanotan II and why the same signal may lead to different observations in different individuals or research conditions.
Important Notice
For research use only. Not intended for human consumption, veterinary use, diagnostic procedures or therapeutic applications. Before use, carefully review the Safety Data Sheet (SDS/MSDS – KBU). Intended only for experienced researchers and professionals familiar with the safe handling of research-grade materials.
Technical Questions (FAQ)
Yes. PT-141 is the research and development name for Bremelanotide. However, this PT-141 10 mg product is supplied strictly as a research material. It is not a pharmaceutical product and should not be used for therapeutic purposes.
No. PT-141 and Melanotan II come from the same wider melanocortin research family, but they are separate peptides with different structures and research profiles.
No. This product is intended only for controlled research use. It is not intended for human consumption, veterinary use, diagnostic procedures or therapeutic applications.
Lyophilization removes water from the material and helps maintain stability during storage. Exact storage, handling and preparation of the solution should always follow the product documentation and Safety Data Sheet.
Scientific Studies and Development Sources
Additional information
| CAS | 189691-06-3 |
|---|
